213 related articles for article (PubMed ID: 15500691)
1. Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.
Suárez-Méndez R; García-García I; Fernández-Olivera N; Valdés-Quintana M; Milanés-Virelles MT; Carbonell D; Machado-Molina D; Valenzuela-Silva CM; López-Saura PA
BMC Infect Dis; 2004 Oct; 4():44. PubMed ID: 15500691
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol.
Condos R; Rom WN; Schluger NW
Lancet; 1997 May; 349(9064):1513-5. PubMed ID: 9167461
[TBL] [Abstract][Full Text] [Related]
3. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
[TBL] [Abstract][Full Text] [Related]
4. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
6. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review.
Gao XF; Yang ZW; Li J
Int J Infect Dis; 2011 Sep; 15(9):e594-600. PubMed ID: 21715206
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.
Milanés-Virelles MT; García-García I; Santos-Herrera Y; Valdés-Quintana M; Valenzuela-Silva CM; Jiménez-Madrigal G; Ramos-Gómez TI; Bello-Rivero I; Fernández-Olivera N; Sánchez-de la Osa RB; Rodríguez-Acosta C; González-Méndez L; Martínez-Sánchez G; López-Saura PA;
BMC Infect Dis; 2008 Feb; 8():17. PubMed ID: 18267006
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
Prasad R; Verma SK; Sahai S; Kumar S; Jain A
Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
[TBL] [Abstract][Full Text] [Related]
11. Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis.
Koh WJ; Kwon OJ; Suh GY; Chung MP; Kim H; Lee NY; Kim TS; Lee KS
J Korean Med Sci; 2004 Apr; 19(2):167-71. PubMed ID: 15082886
[TBL] [Abstract][Full Text] [Related]
12. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
13. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
15. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
Zierski M
Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
[No Abstract] [Full Text] [Related]
16. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
Harries AD; Gausi F; Chimzizi R; Salaniponi FM
Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
[TBL] [Abstract][Full Text] [Related]
17. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
19. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
Tsukamura M
Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
[No Abstract] [Full Text] [Related]
20. [A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
Ramarokoto H; Andrianasolo D; Rasolonavalona T; Ramaroson F; Razafitsiarovana I; Vincent V; Ratsimba L; Rasolofo Razanamparany V
Arch Inst Pasteur Madagascar; 2003; 69(1-2):37-40. PubMed ID: 15678814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]